Mitsubishi Chemical Group Corp. (MCG; Tokyo) announced that it has decided to transfer its consolidated subsidiary Mitsubishi Tanabe Pharma Corp. (MTPC; Osaka, Japan), which manufactures and sells pharmaceutical products, to K.K. BCJ-94, a company indirectly owned by funds advised by Bain Capital Private Equity, LP. Following the transfer, MTPC and its subsidiaries, Medicago Inc., Welfide International Corp., and Alpha Therapeutic Corporation will no longer be specified subsidiaries of MCG.
The specific method of this Transfer is currently under review and will be announced once a decision is made. The completion of the Transfer is expected in the second quarter of FY 3/2026, subject to certain conditions including approval of the Transfer at MCG’s annual shareholders’ meeting and Bain Capital’s obtainment of necessary clearance and approval pursuant to the competition laws and related laws and regulations of Japan and other relevant jurisdictions.